Biomarkers: Discovery Techniques and Applications – A Global Market Overview 2019

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Biomarkers Defined
1.1.2 Biomarkers in Medicine
1.1.2.1 A History of Biomarkers
1.1.2.1.1 Philadelphia Chromosome
1.1.2.1.2 HIV Viral Load
1.1.2.1.3 HER-2 Gene and Receptor
1.1.2.2 Biomarkers for Diseases and Biomarkers for Drugs
1.1.2.3 Prerequisites of Biomarkers
1.1.2.4 Categorization of Biomarkers
1.1.2.4.1 Categorization of Biomarkers based on Types
1.1.2.5 Biomarkers in Drug Development
1.1.2.6 Biomarkers in Diseases
1.1.3 Biomarkers Discovery Technologies
1.1.3.1 Omics Technologies
1.1.3.1.1 Proteomic Methods of Biomarkers Discovery
1.1.3.1.1.1 2D-PAGE (Two-Dimensional Gel Electrophoresis)
1.1.3.1.1.2 LC-MS (Liquid Chromatography Mass Spectrometer)
1.1.3.1.1.3 SELDI-TOF (Surface-Enhanced Laser Desorption/Ionization)
1.1.3.1.1.4 Immunohistochemistry
1.1.3.1.1.5 Antibody (Ab) Microarray
1.1.3.1.1.6 Tissue Microarray
1.1.3.1.2 Genomic Methods of Biomarkers Discovery
1.1.3.1.2.1 Northern Blot
1.1.3.1.2.2 Polymerase Chain Reaction (PCR)
1.1.3.1.2.2.1 Real Time PCR
1.1.3.1.2.3 Gene Expression
1.1.3.1.2.4 Serial Analysis of Gene Expression (SAGE)
1.1.3.1.2.5 DNA Microarray
1.1.3.1.3 Metabolomics Methods of Biomarkers Discovery
1.1.3.1.4 Other Omics Technologies for Biomarkers Discovery
1.1.3.1.4.1 Lipidomics
1.1.3.1.4.2 Glycomics
1.1.3.1.4.3 Secretomics
1.1.3.1.4.3.1 Application of Secretomics in Discovery of Cancer Biomarkers
1.1.3.1.4.3.2 Application of Secretomics in Assisted Reproductive Technologies
1.1.3.2 Imaging Technologies
1.1.3.2.1 Magnetic Resonance Imaging (MRI)
1.1.3.2.2 Computed Tomography (CT)
1.1.3.2.3 Ultrasound (US)
1.1.3.2.4 X-Rays
1.1.3.2.5 Positron Emission Tomography (PET)
1.1.3.2.6 Single Photon Emission Computed Tomography (SPECT)
1.1.3.2.7 Others
1.1.3.3 Bioinformatics
1.1.4 Therapeutic Areas for Biomarkers
1.1.4.1 Cancer Biomarkers
1.1.4.1.1 Cancer Biomarkers Defined
1.1.4.1.2 Functions of Biomarkers in Cancer Medicine
1.1.4.1.2.1 Evaluation of Risk
1.1.4.1.2.2 Diagnosis
1.1.4.1.2.3 Prognosis and Prediction of Therapy
1.1.4.1.2.4 Pharmacodynamics and Pharmacokinetics
1.1.4.1.2.5 Therapy Response Monitoring
1.1.4.1.2.6 Predicting or Monitoring Recurrence of Cancer
1.1.4.1.3 Functions of Biomarkers in Cancer Research
1.1.4.1.3.1 Drug Target Discovery and Development
1.1.4.1.3.2 Surrogate Endpoints
1.1.4.1.4 Categories of Cancer Markers
1.1.4.2 Cardiac Biomarkers
1.1.4.2.1 Measurement Applications of Cardiac Biomarkers
1.1.4.2.2 Classes of Cardiac Marker Tests
1.1.4.2.2.1 Shortcomings of Cardiac Marker Tests
1.1.4.2.3 Biomarkers of Coronary Artery Disease
1.1.4.2.4 Role Played by Innovative Multiple Biomarkers in Predicting Cardiovascular Outcomes
1.1.4.3 Biomarkers for Neurological Disorders
1.1.4.4 Other Therapeutic Areas for Biomarkers
1.1.4.4.1 Biomarkers of Diabetes
1.1.4.4.2 Biomarkers of Aging

2. KEY MARKET TRENDS
2.1 Biomarkers Detection by Glycan Antibody Technique
2.2 Role of Proteomic Techniques in Discovering Gingival Crevicular Fluid Biomarkers Proteomic Technology (GC/MS, MALDI-TOF MS, and LC-MS/MS)
2.3 Novel Biomarkers May Assist Rapid Diagnosis of Autism
2.4 Detection of Autoimmune and Inflammatory Disorders Using Aberrant Non-Coding RNA
2.5 Abnormal miRNA Expression Profiles of T Cells Acts as Biomarkers of Pathogenesis and Ailment in SLE Sufferers
2.6 Combination of sTRA and CA19-9 Test to Detect Pancreatic Cancer Biomarkers
2.7 Proteomics Application to Discover Serum Biomarkers of Kawasaki Disease
2.8 Novel Rheumatoid Arthritis Biomarkers Detected by Researchers
2.9 Discovery of New Kidney Cancer Biomarkers
2.10 Correlation of Novel Inflammatory Biomarkers with Elevated Thrombosis Risk in Cancer Survivors
2.11 Identification of Biomarker for Widespread Heart Failure Type
2.12 Discovery of Novel Imaging Biomarker for Coronary Inflammation
2.13 A Novel Biomarker Based Bioimaging Approach for Kidney Cancer Cell Assessment
2.14 New Biomarker and Therapy for Melanoma has Been Discovered by BU Investigators
2.15 microRNA Signature – A Novel Biomarker Discovered for Postoperative Liver Disorder

3. KEY GLOBAL PLAYERS

• Abbott Diagnostics (United States)
• Agendia NV (The Netherlands)
• Agilent Technologies, Inc. (United States)
• Asuragen, Inc. (United States)
• Beckman Coulter, Inc. (United States)
• Biocartis NV (Belgium)
• bioMérieux SA (France)
• Bio-Rad Laboratories, Inc. (United States)
• Bruker Corporation (United States)
• Caprion Biosciences, Inc. (Canada)
• Charles River Laboratories, Inc. (United States)
• Cisbio Bioassays (France)
• EKF Diagnostics Holdings Plc (United Kingdom)
• Enzo Biochem, Inc. (United States)
• Epigenomics AG (Germany)
• F. Hoffmann-La Roche AG (Switzerland)
• GE Healthcare (United States)
• Genedata AG (Switzerland)
• Genomic Health, Inc. (United States)
• Human Metabolome Technologies (Japan)
• Illumina, Inc. (United States)
• Janssen Pharmaceutica NV (Belgium)
• Koninklijke Philips N.V (The Netherlands)
• Meso Scale Diagnostics LLC. (United States)
• Metabolon, Inc. (United States)
• MilliporeSigma (United States)
• Myriad Genetics, Inc. (United States)
• NanoString Technologies, Inc. (United States)
• Nexus Dx (United States)
• PerkinElmer, Inc. (United States)
• Pharmaceutical Product Development LLC (United States)
• QIAGEN B.V. (The Netherlands)
• Rosetta Genomics (Israel)
• Siemens Healthineers (Germany)
• Singulex, Inc. (United States)
• Thermo Fisher Scientific, Inc.(United States)
• Waters Corporation (United States)

4. KEY BUSINESS AND PRODUCT TRENDS

• therascreen® PIK3CA RGQ PCR Kit, the First FDA-Cleared Companion Diagnostic Assay to detect 11 PIK3CA Gene Mutations
• Establishment of APIS Assay Technologies Ltd. for Broadening Biomarker Research in Europe
• Siemens Releases a Novel Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay for Diabetes
• Development of New Ultra-High Field 18 Tesla MRI System by Bruker and Champalimaud
• Development of Diagnostic Tool for Molecular Biomarker Detection by GE and Indi Molecular
• Epigenomics’ Application for Colorectal Cancer Screening Blood Test Accepted by Centers for Medicare & Medicaid Services for NCD review
• Serametrix Corporation Acquired by Caprion Biosciences
• US FDA Offers 510 (k) Clearance for Beckman Coulter's Early Sepsis Indicator
• Agendia's New Innovation and R&D Excellence Center in the Netherlands
• Abbott's Core Laboratory Instruments to Employ Banyan's Traumatic Brain Injury Blood Biomarkers
• Expansion of Bruker’s MALDI Biotyper, IR Biotyper, and Fluorocycler XT Product Portfolio
• Cisbio Bioassays Acquired by PerkinElmer
• Bio-Rad’s IH-500 Blood Typing and Screening System Receives U.S. FDA Clearance
• NanoString and Leica Biosystems Ink Deal to Market Products for High Throughput Spatial Analysis
• New Immunoassay for Kratom Alkaloid Mitragynine Screening Introduced by Thermo Fisher Scientific
• Bio-Techne and NanoString in Collaboration to Develop Integrated Workflow for RNA Spatial Profiling
• Myriad Introduces Prequel™ Prenatal Screen with all 23 Chromosome Pairs
• Caprion Biosciences Advances Biomarker Discovery and Immune Monitoring by Providing Mass Cytometry Services
• EKF Diagnostics Inks Pact with McKesson to Distribute DiaSpect Tm Hemoglobin Analyzer in the United States
• Grant of European Patent for Singulex High Sensitivity Methods to Quantify Cardiac Troponin
• Genomic Health Develops IVD Version of Idylla™Oncotype DX® GPS™ Test
• Epigenomics Initiates Prospective Clinical Study for Liver Cancer Detection DNA Biomarkers
• Pacific Biosciences to be Taken Over by Illumina to Speed-Up Scientific Discovery
• bioMérieux Reinforces its Immunoassay Offerings by Acquiring Major Shares in Hybiome
• BIOFIRE® FILMARRAY® Pneumonia Panels of bioMérieux Receives CE Mark and FDA Clearance
• Siemens Introduces Magnetom Lumina (3 Tesla) and Magnetom Altea MRI Systems
• USDA Contract Awarded for Bio-Rad’ Pathogen Detection Testing Products
• Epigenomics AG Receives CE Mark for Liquid Biopsy Test for Liver Cancer Detection
• Myriad and Pfizer Inks Deal to Commercialize Myriad’s BRACAnalysis CDx® as a Companion Diagnostic with Pfizer’s Talazoparib
• Healthy.io Join Forces with Siemens to Enhance Kidney Disease Monitorization
• Introduction of TruSight Oncology 500 by Illumina for Pan-Cancer Tumor Profiling
• Setting up of High-field 9.4 Tesla Preclinical PET/MR System at German Cancer Research Center by Bruker
• US Department of Defense Awards Contract to Procure Banyan Brain Trauma Indicator
• Commercial Launch of Singulex Clarity C. diff Toxin A/B Assay
• Agendia in Collaboration with Genecast Offers MammaPrint® and BluePrint® Tests in China for the First Time
• Release of New Preclinical PET/CT Si78 Scanner by Bruker
• Primity Bio Acquired by Caprion Biosciences
• Three Low Cost Cancer Detecting Biomarkers from ENZO Biochem Successfully Validated
• Launch of Shimadzu Q-TOF LCMS-9030 Mass Spectrometer
• Introduction of Novel SKYSCAN 2214 Ultra-High Resolution Nano-CT by Bruker
• Launch of ParaVision® 360 and AVANCE® NEO Systems by Bruker
• NanoString Collaborated with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery
• Thermo Fisher Scientific Opens Precision Medicine Science Center in The United States
• Myriad Genetics to Acquire Counsyl
• Thermo Fisher Scientific Inks Deal with Daiichi Sankyo and Takeda Pharmaceuticals to Expand Oncomine Dx Target Test
• sphingotec to offer penKid® and bio-ADM® Biomarkers on NEXUS IB 10 POC Testing Platform
• Unicancer Chooses Agendia's MammaPrint® and BluePrint® Tests
• Bio-Rad Introduces Bio-Plex Pro human Cytokine Screening Panel
• EKF Wins FDA Clearance for DiaSpect Tm Hemoglobin Analyzer
• Myriad’s BRAC Analysis® Diagnostic System Receives Pre-Market Approval in Japan
• NanoString to Market Digital Spatial Profiling Service through Leading Contract Research Organizations
• NanoString Launches Breast Cancer 360 Research Panel
• Shimadzu Launches UV-1900 UV-VIS Spectrophotometer
• Agreement Signed by Illumina and Loxo to Co-Develop NGS Based Pan-Cancer Companion Diagnostics
• Strengthening of bioMérieux’s Immunoassay Biomarkers Portfolio by Acquiring Astute
• Illumina and Bristol-Myers Squibb Collaborate to Develop and Market CDxs for Cancer Drugs
• Release of Magnetom Sola and BioMatrix Technology by Siemens to Expand Personalized Medicine
• Siemens Introduces a Novel Acuson Juniper Next-Generation Ultrasound System
• Metabolon's Meta UDx™ Test is Now Available for Difficult-to-Diagnose Patient Cases
• Launch of Shimadzu's Nexera Mikros Microflow Liquid Chromatography Mass Spectrometry System
• Launch of Genedata Profiler® 11.0 Enterprise Software Platform for Omics-based Profiling of Patients
• Banyan Biomarkers Receives FDA Grant for the Commercialization of the First IVD Blood Test for TBI
• US FDA Approves Myriad’s BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Metastatic Breast Cancer
• Myriad Genetics Strengthens Research Collaboration with AstraZeneca
• NanoString and RikenGenesis to Commercialize nCounter-Based Diagnostic Assays in Japan
• AMPIPROBE® Women’s Health Panel Launched by Enzo Clinical Labs
• Collaborative NGS Technology Development Deal Signed by Illumina and KingMed
• Fast Track Diagnostics Completely Taken Over by Siemens
• Siemens Collaborates With Circle Cardiovascular to Improve Cardiac Imaging
• Epigenomics Receives CE-IVD Mark for Lung Cancer Test Epi proLung®
• Agendia Collaborates with Bluebee to Launch MammaPrint® BluePrint® Breast Cancer Recurrence and Molecular Subtyping Kit
• sphingotec and Ortho Jointly Offer sphingotest® bio-ADM® Assay for Clinical Laboratories Globally
• Agendia and Institute Curie Partners for the Co-validation Study of MammaPrint® BluePrint® Kit
• sphingotec and Mayo Clinic Partner to Assess Four Biomarkers
• EKF’s Procalcitonin Assay Wins FDA Clearance and Validated for Beckman AU Chemistry Analyzers
• Genomic Health Develops New Prostate Cancer Tests based on Cleveland Diagnostics' IsoPSA™ Reagent and SIA Technology
• Release of NextSeq™ 550Dx System by Illumina and Extends the Application of MiSeqTM Dx System
• Ortho Clinical Diagnostics to Use EKF Diagnostics’ Diabetic Ketoacidosis Assay
• Thermo Fisher Scientific and Blueprint Medicines Ink Deal for Oncology Companion Diagnostic Development
• Expansion of laboratory Hematology Solutions by Siemens and HORIBA
• Grant of Patent for Singulex Methods to Digitally Detect Single Molecules of Cardiac Troponin
• Scientific Collaboration of Caprion Biosciences with the FNIK Biomarkers Consortium
• sphingotec Collaborates with Shuwen for Biomarkers Marketing in China
• Publication of a New Blood Protein Study for Predictive Tuberculosis Infection Using ProteoCarta™ Biomarker Panel
• VITEK® MS of bioMérieux Receives FDA Approval for Extended Pathogen Detection
• US FDA Clearance for Bio-Rad‘s BioPlex 2200 Syphilis Total & RPR Assay Testing Method
• Thermo Fisher’s Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies Approved by FDA
• BioFire's FilmArray® Respiratory Panel 2 of boMérieux Obtains FDA Authorization
• Extended RAS Panel of Illumina Receives FDA Approval
• CE Mark for Singulex'First Ultrasensitive Cardiac Troponin Assay Powered by Single Molecule Counting Technology
• EKF to Distribute Procalcitonin LiquiColor® Test into Eastern Europe, Middle East, and APAC
• sphingotec and bestbion dx form Acute Care Biomarkers Marketing Pact
• Joint collaboration of Metabolon and ADLQ to Set up Metabolomics Platform in Qatar
• Myriad Genetics and BeiGene to Develop Companion Diagnostics for BeiGene's BGB-290 PARP Inhibitor
• European Release of VeriSeq™ NIPT Solution by Illumina
• BacT/ALERT® VIRTUO Blood Culture System of bioMérieux Gains FDA 510(k) Approval
• bioMérieux Receives CE Approval for FilmArray® Respiratory Panel 2 plus
• European CE Mark for Singulex' Sgx Clarity® System
• Expansion of Clinical Assessment of Singulex Sgx Clarity™ System at European Research Sites
• New V-PLEX® Assays for Th17 Research Introduced by Meso Scale Discovery
• VIDAS® B.R.A.H.M.S PCT™ of bioMérieux Receives FDA Approval for Respiratory Infection and Sepsis
• Metabolon partners with Dian to Establish Discovery HD4™ Platform in China
• bioMérieux inks Deal with Banyan Biomarkers for Development and Commercialization of Blood-Based Biomarkers for TBI
• Singulex and QIAGEN Partners for Companion DiagnosticsDevelopment
• Commercial Release of Vectra® Polaris™ Pathology Imaging System by PerkinElmer
• Illumina Signs Integrated Genomics Solutions Deal with Philips

5. GLOBAL MARKET OVERVIEW
5.1 Global Biomarkers Market Overview by Discovery Technology
5.1.1 Global Omics Technologies for Biomarkers Market Overview by Segment
5.1.1.1 Omics Technology Segments Market Overview by Global Region
5.1.1.1.1 Proteomics
5.1.1.1.2 Genomics
5.1.1.1.3 Metabolomics
5.1.1.1.4 Other Omics Technologies
5.1.2 Global Bioimaging Market Overview by Modality
5.1.2.1 Bioimaging Modalities Market Overview by Global Region
5.1.2.1.1 MRI
5.1.2.1.2 CT
5.1.2.1.3 Ultrasound
5.1.2.1.4 Other Bioimaging Modalities
5.1.3 Biomarkers Discovery Technology Market Overview by Global Region
5.1.3.1 Omics Technologies
5.1.3.2 Bioimaging
5.1.3.3 Bioinformatics
5.2 Global Biomarkers Market Overview by Therapeutic Area
5.2.1 Biomarkers Therapeutic Area Market Overview by Global Region
5.2.1.1 Oncology
5.2.1.2 Cardiology
5.2.1.3 Neurology
5.2.1.4 Other Therapeutic Areas

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA
6.1 North American Biomarkers Market Overview by Geographic Region
6.2 North American Biomarkers Market Overview by Discovery Technology
6.2.1 North American Omics Technologies Market Overview by Segment
6.2.2 North American Bioimaging Market Overview by Modality
6.2.3 Biomarkers Discovery Technology Market Overview by NA Region
6.2.3.1 Omics Technologies
6.2.3.2 Bioimaging
6.2.3.3 Bioinformatics
6.3 North American Biomarkers Market Overview by Therapeutic Area
6.4 Major Market Players

• Abbott Diagnostics (United States)
• Agilent Technologies, Inc. (United States)
• Altheadx, Inc. (United States)
• Asuragen, Inc. (United States)
• Banyan Biomarkers, Inc. (United States)
• Beckman Coulter, Inc. (United States)
• BG Medicine, Inc. (United States)
• Bio-Rad Laboratories, Inc. (United States)
• Bruker Corporation (United States)
• Caprion Biosciences, Inc. (Canada)
• Charles River Laboratories, Inc. (United States)
• ENZO Biochem, Inc. (United States)
• GE Healthcare (United States)
• Genomic Health, Inc. (United States)
• Illumina, Inc. (United States)
• Life Diagnostics, Inc. (United States)
• Lifesign LLC. (United States)
• Meso Scale Diagnostics LLC. (United States)
• Metabolon, Inc. (United States)
• Milliporesigma (United States)
• Myriad Genetics, Inc. (United States)
• Myriad RBM (United States)
• Nanostring Technologies, Inc. (United States)
• Nexus DX (United States)
• Perkinelmer, Inc. (United States)
• Pharmaceutical Product Development LLC (United States)
• Shimadzu Scientific Instruments (United States)
• Signosis, Inc. (United States)
• Singulex, Inc. (United States)
• Stagezero Life Sciences, Inc. (Canada)
• Thermo Fisher Scientific, Inc. (United States)
• Waters Corporation (United States)

6.5 Country-wise Analysis of North American Biomarkers Market
6.5.1 The United States
6.5.1.1 United States Biomarkers Market Overview by Discovery Technology
6.5.2 Canada
6.5.2.1 Canadian Biomarkers Market Overview by Discovery Technology
6.5.3 Mexico
6.5.3.1 Mexican Biomarkers Market Overview by Discovery Technology

7. EUROPE
7.1 European Biomarkers Market Overview by Geographic Region
7.2 European Biomarkers Market Overview by Discovery Technology
7.2.1 European Omics Technologies Market Overview by Segment
7.2.2 European Bioimaging Market Overview by Modality
7.2.3 Biomarkers Discovery Technology Market Overview by European Region
7.2.3.1 Omics Technologies
7.2.3.2 Bioimaging
7.2.3.3 Bioinformatics
7.3 European Biomarkers Market Overview by Therapeutic Area
7.4 Major Market Players

• Agendia Nv (The Netherlands)
• Akuru Pharma AB (Sweden)
• Bayer Pharma AG (Germany)
• Biocartis NV (Belgium)
• Biomérieux SA (France)
• Biosystems International Kft (Hungary)
• Cisbio Bioassays (France)
• Decode Genetics (Iceland)
• EKF Diagnostics Holdings Plc (United Kingdom)
• Epigenomics AG (Germany)
• F. Hoffmann-La Roche AG (Switzerland)
• Genedata AG (Switzerland)
• Janssen Pharmaceutica NV (Belgium)
• Koninklijke Philips N.V (The Netherlands)
• Pamgene International B.V. (The Netherlands)
• Qiagen B.V. (The Netherlands)
• Siemens Healthineers (Germany)

7.5 Country-wise Analysis of European Biomarkers Market
7.5.1 Germany
7.5.1.1 German Biomarkers Market Overview by Discovery Technology
7.5.2 The United Kingdom
7.5.2.1 United Kingdom Biomarkers Market Overview by Discovery Technology
7.5.3 France
7.5.3.1 French Biomarkers Market Overview by Discovery Technology
7.5.4 Italy
7.5.4.1 Italian Biomarkers Market Overview by Discovery Technology
7.5.5 Spain
7.5.5.1 Spanish Biomarkers Market Overview by Discovery Technology
7.5.6 Sweden
7.5.6.1 Swedish Biomarkers Market Overview by Discovery Technology
7.5.7 Rest of Europe
7.5.7.1 Rest of Europe Biomarkers Market Overview by Discovery Technology

8. ASIA-PACIFIC
8.1 Asia-Pacific Biomarkers Market Overview by Geographic Region
8.2 Asia-Pacific Biomarkers Market Overview by Discovery Technology
8.2.1 Asia-Pacific Omics Technologies Market Overview by Segment
8.2.2 Asia-Pacific Bioimaging Market Overview by Modality
8.2.3 Biomarkers Discovery Technology Market Overview by Asia-Pacific Region
8.2.3.1 Omics Technologies
8.2.3.2 Bioimaging
8.2.3.3 Bioinformatics
8.3 Asia-Pacific Biomarkers Market Overview by Therapeutic Area
8.4 Human Metabolome Technologies (Japan) - A Major Market Player
8.5 Country-wise Analysis of Asia-Pacific Biomarkers Market
8.5.1 China
8.5.1.1 Chinese Biomarkers Market Overview by Discovery Technology
8.5.2 Japan
8.5.2.1 Japanese Biomarkers Market Overview by Discovery Technology
8.5.3 India
8.5.3.1 Indian Biomarkers Market Overview by Discovery Technology
8.5.4 Australia
8.5.4.1 Australian Biomarkers Market Overview by Discovery Technology
8.5.5 Rest of Asia-Pacific
8.5.5.1 Rest of Asia-Pacific Biomarkers Market Overview by Discovery Technology

9. REST OF WORLD
9.1 Rest of World Biomarkers Market Overview by Discovery Technology
9.1.1 Rest of World Omics Technologies Market Overview by Segment
9.1.2 Rest of World Bioimaging Market Overview by Modality
9.2 Rest of World Biomarkers Market Overview by Therapeutic Area
9.3 Rosetta Genomics (Israel) - A Major Market Player

PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACKCharts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Biomarkers Market 2018 and 2025 by Geographic Region
Chart 2: Global Biomarkers Market 2018 and 2025 by Discovery Technology
Chart 3: Global Biomarkers Market 2018 and 2025 by Application
Chart 4: Global Biomarkers Market Analysis (2016-2025) in USD Million
Chart 5: Global Biomarkers Market Analysis (2016-2025) by Discovery Technology – Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 6: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) by Discovery Technology – Omics Technologies, Bioimaging and Bioinformatics
Chart 7: Global Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment – Proteomics, Genomics, Metabolomics and Other in USD Million
Chart 8: Glance at 2016, 2019 and 2025 Global Omics Technologies for Biomarkers Discovery Market Share (%) by Segment – Proteomics, Genomics, Metabolomics and Other
Chart 9: Global Proteomics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 10: Glance at 2016, 2019 and 2025 Global Proteomics for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 11: Global Genomics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 12: Glance at 2016, 2019 and 2025 Global Genomics for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 13: Global Metabolomics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 14: Glance at 2016, 2019 and 2025 Global Metabolomics for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 15: Global Other Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 16: Glance at 2016, 2019 and 2025 Global Other Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 17: Global Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality – MRI, CT, Ultrasound and Other in USD Million
Chart 18: Glance at 2016, 2019 and 2025 Global Bioimaging for Biomarkers Discovery Market Share (%) by Modality – MRI, CT, Ultrasound and Other
Chart 19: Global MRI for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 20: Glance at 2016, 2019 and 2025 Global MRI for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 21: Global CT for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 22: Glance at 2016, 2019 and 2025 Global CT for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 23: Global Ultrasound for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 24: Glance at 2016, 2019 and 2025 Global Ultrasound for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 25: Global Other Bioimaging Modalities for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 26: Glance at 2016, 2019 and 2025 Global Other Bioimaging Modalities for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 27: Global Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2016, 2019 and 2025 Global Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 29: Global Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 30: Glance at 2016, 2019 and 2025 Global Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 31: Global Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 32: Glance at 2016, 2019 and 2025 Global Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 33: Global Biomarkers Market Analysis (2016-2025) by Therapeutic Area – Oncology, Cardiology, Neurology and Other in USD Million
Chart 34: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) by Therapeutic Area – Oncology, Cardiology, Neurology and Other
Chart 35: Global Biomarkers Market Analysis (2016-2025) in Oncology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in US$ Million
Chart 36: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Oncology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 37: Global Biomarkers Market Analysis (2016-2025) in Cardiology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in US$ Million
Chart 38: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Cardiology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 39: Global Biomarkers Market Analysis (2016-2025) in Neurology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in US$ Million
Chart 40: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Neurology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 41: Global Biomarkers Market Analysis (2016-2025) in Other Therapeutic Areas by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in US$ Million
Chart 42: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Other Therapeutic Areas by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE
Chart 43: Global Biomarkers Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
Chart 44: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 45: North American Biomarkers Market Analysis (2016-2025) in USD Million
Chart 46: North American Biomarkers Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in US$ Million
Chart 47: Glance at 2016, 2019 and 2025 North American Biomarkers Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 48: North American Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 49: Glance at 2016, 2019 and 2025 North American Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
Chart 50: North American Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
Chart 51: Glance at 2016, 2019 and 2025 North American Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
Chart 52: North American Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
Chart 53: Glance at 2016, 2019 and 2025 North American Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
Chart 54: North American Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 55: Glance at 2016, 2019 and 2025 North American Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 56: North American Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 57: Glance at 2016, 2019 and 2025 North American Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 58: North American Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 59: Glance at 2016, 2019 and 2025 North American Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 60: North American Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
Chart 61: Glance at 2016, 2019 and 2025 North American Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

The United States
Chart 62: United States Biomarkers Market Analysis (2016-2025) in USD Million
Chart 63: United States Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 64: Glance at 2016, 2019 and 2025 United States Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Canada
Chart 65: Canadian Biomarkers Market Analysis (2016-2025) in USD Million
Chart 66: Canadian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 67: Glance at 2016, 2019 and 2025 Canadian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Mexico
Chart 68: Mexican Biomarkers Market Analysis (2016-2025) in USD Million
Chart 69: Mexican Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 70: Glance at 2016, 2019 and 2025 Mexican Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

EUROPE
Chart 71: European Biomarkers Market Analysis (2016-2025) in USD Million
Chart 72: European Biomarkers Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in US$ Million
Chart 73: Glance at 2016, 2019 and 2025 European Biomarkers Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 74: European Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 75: Glance at 2016, 2019 and 2025 European Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
Chart 76: European Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
Chart 77: Glance at 2016, 2019 and 2025 European Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
Chart 78: European Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
Chart 79: Glance at 2016, 2019 and 2025 European Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
Chart 80: European Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 81: Glance at 2016, 2019 and 2025 European Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 82: European Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 83: Glance at 2016, 2019 and 2025 European Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 84: European Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
Chart 85: Glance at 2016, 2019 and 2025 European Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
Chart 86: European Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
Chart 87: Glance at 2016, 2019 and 2025 European Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

Germany
Chart 88: German Biomarkers Market Analysis (2016-2025) in USD Million
Chart 89: German Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 90: Glance at 2016, 2019 and 2025 German Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

The United Kingdom
Chart 91: United Kingdom Biomarkers Market Analysis (2016-2025) in USD Million
Chart 92: United Kingdom Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 93: Glance at 2016, 2019 and 2025 United Kingdom Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

France
Chart 94: French Biomarkers Market Analysis (2016-2025) in USD Million
Chart 95: French Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 96: Glance at 2016, 2019 and 2025 French Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Italy
Chart 97: Italian Biomarkers Market Analysis (2016-2025) in USD Million
Chart 98: Italian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 99: Glance at 2016, 2019 and 2025 Italian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Spain
Chart 100: Spanish Biomarkers Market Analysis (2016-2025) in USD Million
Chart 101: Spanish Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 102: Glance at 2016, 2019 and 2025 Spanish Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Sweden
Chart 103: Swedish Biomarkers Market Analysis (2016-2025) in USD Million
Chart 104: Swedish Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 105: Glance at 2016, 2019 and 2025 Swedish Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Rest of Europe
Chart 106: Rest of Europe Biomarkers Market Analysis (2016-2025) in USD Million
Chart 107: Rest of Europe Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 108: Glance at 2016, 2019 and 2025 Rest of Europe Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

ASIA-PACIFIC
Chart 109: Asia-Pacific Biomarkers Market Analysis (2016-2025) in USD Million
Chart 110: Asia-Pacific Biomarkers Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in US$ Million
Chart 111: Glance at 2016, 2019 and 2025 Asia-Pacific Biomarkers Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
Chart 112: Asia-Pacific Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 113: Glance at 2016, 2019 and 2025 Asia-Pacific Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
Chart 114: Asia-Pacific Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
Chart 115: Glance at 2016, 2019 and 2025 Asia-Pacific Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
Chart 116: Asia-Pacific Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
Chart 117: Glance at 2016, 2019 and 2025 Asia-Pacific Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
Chart 118: Asia-Pacific Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in USD Million
Chart 119: Glance at 2016, 2019 and 2025 Asia-Pacific Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
Chart 120: Asia-Pacific Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in USD Million
Chart 121: Glance at 2016, 2019 and 2025 Asia-Pacific Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
Chart 122: Asia-Pacific Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in USD Million
Chart 123: Glance at 2016, 2019 and 2025 Asia-Pacific Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
Chart 124: Asia-Pacific Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
Chart 125: Glance at 2016, 2019 and 2025 Asia-Pacific Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

China
Chart 126: Chinese Biomarkers Market Analysis (2016-2025) in USD Million
Chart 127: Chinese Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 128: Glance at 2016, 2019 and 2025 Chinese Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Japan
Chart 129: Japanese Biomarkers Market Analysis (2016-2025) in USD Million
Chart 130: Japanese Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 131: Glance at 2016, 2019 and 2025 Japanese Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

India
Chart 132: Indian Biomarkers Market Analysis (2016-2025) in USD Million
Chart 133: Indian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 134: Glance at 2016, 2019 and 2025 Indian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Australia
Chart 135: Australian Biomarkers Market Analysis (2016-2025) in USD Million
Chart 136: Australian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 137: Glance at 2016, 2019 and 2025 Australian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Rest of Asia-Pacific
Chart 138: Rest of Asia-Pacific Biomarkers Market Analysis (2016-2025) in USD Million
Chart 139: Rest of Asia-Pacific Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 140: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

REST OF WORLD
Chart 141: Rest of World Biomarkers Market Analysis (2016-2025) in USD Million
Chart 142: Rest of World Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
Chart 143: Glance at 2016, 2019 and 2025 Rest of World Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
Chart 144: Rest of World Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
Chart 145: Glance at 2016, 2019 and 2025 Rest of World Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
Chart 146: Rest of World Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
Chart 147: Glance at 2016, 2019 and 2025 Rest of World Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
Chart 148: Rest of World Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
Chart 149: Glance at 2016, 2019 and 2025 Rest of World Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

Tables:
Table 1: Biomarkers Role in Drug Discovery and Development Protocols

Companies Mentioned

•  Abbott Diagnostics (United States)
• Agendia Nv (The Netherlands)
• Agilent Technologies, Inc. (United States)
• Akuru Pharma AB (Sweden)
• Altheadx, Inc. (United States)
• APIS Assay Technologies Ltd.
• Astute
• Asuragen, Inc. (United States)
• Banyan Biomarkers, Inc. (United States)
• Bayer Pharma AG (Germany)
• Beckman Coulter, Inc. (United States)
• BeiGene
• bestbion dx
• BG Medicine, Inc. (United States)
• Bio-Rad Laboratories, Inc. (United States)
• Biocartis NV (Belgium)
• bioMérieux SA (France)
• Biosystems International Kft (Hungary)
• Blueprint Medicines
• Bristol-Myers Squibb
• Bruker Corporation (United States)
• Caprion Biosciences, Inc. (Canada)
• Charles River Laboratories, Inc. (United States)
• Cisbio Bioassays (France)
• Counsyl
• Daiichi Sankyo
• Decode Genetics (Iceland)
• EKF Diagnostics Holdings Plc (United Kingdom)
• Enzo Biochem, Inc. (United States)
• Epigenomics AG (Germany)
• F. Hoffmann-La Roche AG (Switzerland)
• FNIK Biomarkers Consortium
• GE Healthcare (United States)
• Genecast
• Genedata AG (Switzerland)
• Genomic Health, Inc. (United States)
• Healthy.io
• HORIBA
• Human Metabolome Technologies (Japan)
• Illumina, Inc. (United States)
• Indi Molecular
• Janssen Pharmaceutica NV (Belgium)
• Koninklijke Philips N.V (The Netherlands)
• Life Diagnostics, Inc. (United States)
• Lifesign LLC. (United States)
• Loxo
• McKesson
• Meso Scale Diagnostics LLC. (United States)
• Metabolon, Inc. (United States)
• Milliporesigma (United States)
• Myriad Genetics, Inc. (United States)
• Myriad RBM (United States)
• Nanostring Technologies, Inc. (United States)
• Nexus Dx (United States)
• Ortho Clinical Diagnostics
• Pacific Biosciences
• Pamgene International B.V. (The Netherlands)
• Perkinelmer, Inc. (United States)
• Pfizer
• Pharmaceutical Product Development LLC (United States)
• Primity Bio
• Qiagen B.V. (The Netherlands)
• Rosetta Genomics (Israel)
• Serametrix Corporation
• Shimadzu Scientific Instruments (United States)
• Shuwen
• Siemens Healthineers (Germany)
• Signosis, Inc. (United States)
• Singulex, Inc. (United States)
• Sphingotec
• Stagezero Life Sciences, Inc. (Canada)
• Takeda Pharmaceuticals
• Thermo Fisher Scientific, Inc. (United States)
• Thermo Fisher Scientific, Inc.(United States)
• Unicancer
• Waters Corporation (United States)